SCHEMBL29616631

SCHEMBL29616631

Clc1ccc(-c2nc(C3CN(C(c4ccccc4)c4ccccc4)C3)no2)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.45
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
TP53 P04637 2/20 0.39
HPGD P15428 2/20 0.39
TSHR P16473 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
AOC3 Q16853 2/20 0.37
DPP4 P27487 1/20 0.36
DPP7 Q9UHL4 1/20 0.36
POLB P06746 3/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23149068 1.00 GRM5 (0.45) GRM5CHRM1CHRM3NPC1RAB9A
Hydrochloric Acid SCHEMBL29616565 0.73 CHRM1 (0.47) GRM5CHRM1CHRM3NPC1RAB9A
Hydrochloric Acid SCHEMBL23148960 0.73 CHRM1 (0.47) GRM5CHRM1CHRM3NPC1RAB9A
SCHEMBL30488782 0.69 CPT2 (0.48) TSHRL3MBTL1POLBLMNACASP3
SCHEMBL25290141 0.69 CPT2 (0.48) TSHRL3MBTL1POLBLMNACASP3
SCHEMBL6781064 0.66 CHRM2 (0.53) CHRM1TSHRNPSR1SMN1; SMN2ALDH1A1
SCHEMBL21889030 0.66 AOC3 (0.54) CHRM1CHRM3NPC1RAB9ATP53
SCHEMBL7396263 0.66 NPC1 (0.52) CHRM1CHRM3NPC1RAB9AHPGD
SCHEMBL25254795 0.64 NPSR1 (0.32) TP53NPSR1SMN1; SMN2ALDH1A1LMNA
SCHEMBL6980247 0.64 ALDH1A1 (0.40) CHRM1CHRM3HPGDSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114401968-A Novel heterocyclic monoacylglycerol lipase (MAGL) inhibitors 豪夫迈·罗氏有限公司 2022-04-26 CN disclosed